Palo Alto – November 24, 2025 – WCP is delighted to release the Spatial Omics Industry Report Nov 2025, authored by Joseph Galasso, Strategic Advisor to WCP and PhD Candidate at UCLA, by senior bankers Juliesta Sylvester PhD and Michael Magnani, and by analyst Ted Celentino.
The report covers the following key points and more:
- Spatial profiling of molecular biomarkers is the next growth phase for targeted personalized medicine
- What Acquirers consider as they balance the short- and long-term outlook for emerging tech trends
- Promising acquisition targets in spatial omics offer unique technologies and coverage
- Which Acquirers are leading in Spatial Omics, based on past M&A deals and strategic coverage gaps
- Notable investors often bundle omics and spatial biology targets
- Funding dynamics reveal a market aimed at consolidation
- Valuations grow steadily with company growth stage across Omics and Spatial Biology
- Our selection of promising targets worth consideration
Get the report here:
Woodside Capital Partners is a leading corporate finance advisory firm for tech companies in M&A and financings in the $30M –$500M enterprise value segment. The firm has worked with extraordinary entrepreneurs and investors since 2001, providing ultra-personalized service to its clients. Our team has global vision and reach, and has completed hundreds of successful engagements. We have deep industry knowledge and extensive domain and transaction experience in these and other sectors: Artificial Intelligence, CyberSecurity, HR Tech, Digital Advertising and Marketing, Autonomous Vehicles, ADAS, Computer Vision, Aerospace and Defense, CloudTech, Enterprise Software, IT Services, Information Security, FinTech, Internet of Things, Networking / Infrastructure, Robotics, Semiconductors, Quantum, Energy Storage, Digital Health & Virtual Care, Diagnostic, Medical Devices & Precision Medicine, Healthcare IT & Data Analytics Platforms, AI & Automation in Clinical Decision Support, Revenue Cycle Management & Financial Ops, Behavioral & Mental Health Tech, Value-Based Care & Preventive/Wellness Platforms, Healthcare Infrastructure & Cybersecurity. Woodside Capital Partners is a specialist in cross-border transactions, and has extensive relationships among venture capitalists, private equity investors, and corporate executives from Global 1000 companies.
Questions? Please contact Juliesta Sylvester PhD, Managing Director, Woodside Capital Partners at jsylvester@woodsidecap.com.